You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
High Dynamic Range Multi-Carrier Amplifier (HDR MCA)
SBC: MAXENTRIC TECHNOLOGIES LLC Topic: N181088Navy’s digital modular radios (DMRs) have been upgraded to support a wide range of waveforms (e.g. SRW, HAVE QUICK, SINCGARS, SATCOM, and MUOS). To further increase the fleet’s warfighting capability, the U.S. Navy is interested in reducing the number of single function RF systems required on Navy ships and submarines. EMBARC (Efficient Multi-carrier Broadband Amplifier for Radio Communication ...
SBIR Phase II 2019 Department of DefenseNavy -
Integrating a suite of mental health apps for depression in a healthcare setting.
SBC: Adaptive Health, Inc. Topic: 104Abstract Depression is common, imposing a tremendous societal burden in terms of cost, morbidity, quality of life, and mortality. The great majority of people with depression are treated in primary care, however outcomes remain poor. There have been two broad attempts to address this problem. One is collaborative care, which uses care managers to coordinate patient care. Collaborative care can be ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
4-(Aminomethyl) benzamides as novel anti-Ebola agents
SBC: Chicago Biosolutions, Inc. Topic: NIAIDEbola (EBOV) and Marburg (MARV) viruses belong to the Filoviridae family and can cause fatal hemorrhagic fevers characterized by widespread tissue destruction after an incubation period of 4-14 days. Due to safety concerns, these viruses are designated as biosafety level 4 agents. Currently, there is no effective vaccine or therapeutic treatment for filoviral infections in humans. Africa has recen ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Long-term therapeutic effects of synthetic bryostatin-1 in advanced AD without memantine
SBC: SYNAPTOGENIX, INC. Topic: RProgram Director/Principal Investigator (Last, First, Middle): Miao-Kun Sun Project Summary/Abstract The importance of memory impairment and dementias, including Alzheimer’s disease (AD), as a global priority has been well recognized. Many compounds that target AD pathologies have been developed preclinically but have failed in clinical trials, mostly for the lack of therapeutic efficacies.Neuro ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
HIGH TEMPERATURE SUPERCONDUCTIVITY (HTSC) ESM AUGMENTATION SYSTEM
SBC: ELECTRO-RADIATION, INC. Topic: N/ATHE PROJECT EXAMINES THE FEASIBILITY OF APPLYING HIGH TEMPERATURE SUPERCONDUCTIVITY (HTSC) TECHNOLOGY TO AUGMENT ESM RECEIVER SYSTEMS. HTSC IS AN ENABLING TECHNOLOGY WHICH POTENTIALLY ALLOWS A DEVICE TO BE CONSTRUCTED WHICH SORTS HIGH DUTY CYCLE (PULSE) SIGNALS AT DIRECT RF. THE ISOLATED PD/CW AND PULSE ENVIRONMENTS SRE THEN EASILY HANDLED BY SIMPLE SUPERHET AND WIDE BAND RECEIVERS, RESPECTIVELY. ...
SBIR Phase II 1992 Department of DefenseAir Force -
Improvement of Preclinical Oxygen Imager JIVA-25
SBC: O2M TECHNOLOGIES LLC Topic: NCIAbstract JIVA-25 is a small footprint 25 mT preclinical oxygen imager based on the principles of electron paramagnetic resonance oxygen imaging. JIVA-25 can provide oxygen maps in tissues with 1 mm spatial resolution, 1 torr oxygen resolution, and 1-10 min temporal resolution. No other competing method can provide accurate noninvasive pO2 maps with such precision. In tumors, accurate real-time pO2 ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Enhanced Lower Cost Tooling for Friction Stir Technologies
SBC: QUESTEK INNOVATIONS LLC Topic: N18AT026Under this Phase II STTR program, QuesTek Innovations LLC will continue to build on the ICME approach outlined in Phase I efforts to advance the development of a novel cost-effective cermet material for friction stir welding (FSW) tools with excellent properties and maximized ratio of tool lifetime to tool cost. QuesTek will apply its demonstrated expertise in computational materials design method ...
STTR Phase II 2019 Department of DefenseNavy -
On Demand Structures-Submarine Launch of UUVs
SBC: LBI, Inc. Topic: NX19002The need to launch Unmanned Underwater Vehicles from a 21" torpedo tube environment is of interest. To address this need, a carbon fiber composite sabot system utilizing advanced materials is proposed. The Unmanned Underwater Vehicle Sabot System (UUVSS) will be designed to function within a 21" torpedo tube environment on Virginia Class submarines. The proposed technology will be fabricated, test ...
SBIR Phase II 2019 Department of DefenseNavy -
Restoring Beta-lactam efficacy against methicillin-resistant Staphylococci
SBC: Prokaryotics, Inc. Topic: NIAIDMethicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus epidermidis (MRSE) are a major cause of bloodstream infections in the hospital and in the community. Indeed, MRSA remains the second leading cause of mortality by drug-resistant bacterial pathogens in the USA. Although two mechanistically novel antibiotic classes exist to treat such infections (Daptomycin; ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
Developing a peptide-based oral drug to prevent kidney stones
SBC: Oxalo Therapeutics, Inc. Topic: 400Project Summary/Abstract Kidney stones (KS) are highly prevalent, excruciating, and associated with long term complications of chronic kidney disease (CKD) and end stage renal disease (ESRD). They account for 1.3M ER visits and andgt;$10B of medical costs annually and have a striking recurrence rate of 50% in 5 years and up to 80% in 10 years, reflecting the inadequacies of current interventions. ...
STTR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health